Treos Bio ^Companies

Treos Bio is a computational immunology and immunotherapy company that develops precision cancer immunotherapies tailored to patients' genetics. They have developed a proprietary technology to predict likely responders to cancer immunotherapies and design targeted immunotherapies for a large population of cancer patients. Treos Bio uses therapeutic peptides to stimulate cancer-specific immune responses in patients predicted to respond, without the need for tumor biopsy. Their subsidiary, PepTC Vaccines, focuses on developing an effective and safe vaccine against SARS-CoV-2, addressing the challenges of individual immune response heterogeneity and structural variations in the virus.